Moderna, Inc.
MRNANasdaqFull coverage
Price
Loading your watchlists
Income statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions · shares in millions · per-share in USD · per-share values and share counts not split-adjusted
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, | FY 2018Ended Dec 31, | FY 2017Ended Dec 31, | FY 2016Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Cost of revenue | |||||||||||
| Gross profit | |||||||||||
| Research and development | |||||||||||
| Selling, general and administrative | |||||||||||
| General and administrative | |||||||||||
| Operating expenses | |||||||||||
| Total costs and expenses | |||||||||||
| Operating income | |||||||||||
| Interest income | |||||||||||
| Non-operating income (expense), net | |||||||||||
| Other non-operating income (expense) | |||||||||||
| Income before taxes | |||||||||||
| Income tax | |||||||||||
| Net income | |||||||||||
| Net income available to common shareholders | |||||||||||
| Basic EPS | |||||||||||
| Diluted EPS | |||||||||||
| Weighted average shares (basic) | |||||||||||
| Weighted average shares (diluted) | |||||||||||
| Other comprehensive income, including non-controlling interests | |||||||||||
| Foreign currency translation | |||||||||||
| Other comprehensive income | |||||||||||
| Comprehensive income | |||||||||||
| Lease cost | |||||||||||
| Operating lease cost | |||||||||||
| Finance lease amortization | |||||||||||
| Finance lease interest | |||||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Free cash flow | ||||
| Diluted share count |
Margins
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin | ||||||||||||||||||||
| FCF margin |